Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Witt

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
JAMA Internal Medicine|April 21, 2015
Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism studyMargaret C Fang, Dongjie Fan, Sue Hee Sung, et al.
Thrombosis Research|September 26, 2020
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolismThomas Delate, Malti Charlu, Shiyun Zhu, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2025
The clot cases conference: a proposed model to enhance multidisciplinary thrombosis careAnna L Parks, Stephen L Jenkins, Sara R Vazquez, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2026
A qualitative study of warfarin self-management in the United States healthcare system: insights from patient experiencesSpencer J Gilbert, Heeseung Hong, Aubrey E Jones, et al.
Pharmacotherapy|July 29, 2008
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR studyNathan P Clark, Daniel M Witt, Thomas Delate, et al.
Blood Advances|March 10, 2019
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysisRasha Khatib, Maja Ludwikowska, Daniel M Witt, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
Archives of Internal Medicine|September 19, 2012
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleedingDaniel M Witt, Thomas Delate, David A Garcia, et al.
The American Journal of Medicine|February 21, 2023
Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus PanelRachel P Rosovsky, Eva Kline-Rogers, Leslie Lake, et al.
Plos One|January 29, 2025
The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adultsAnna L Parks, Stacey L Slager, Amy M Cizik, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
JAMA Internal Medicine|April 21, 2015
Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism studyMargaret C Fang, Dongjie Fan, Sue Hee Sung, et al.
Thrombosis Research|September 26, 2020
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolismThomas Delate, Malti Charlu, Shiyun Zhu, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2025
The clot cases conference: a proposed model to enhance multidisciplinary thrombosis careAnna L Parks, Stephen L Jenkins, Sara R Vazquez, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2026
A qualitative study of warfarin self-management in the United States healthcare system: insights from patient experiencesSpencer J Gilbert, Heeseung Hong, Aubrey E Jones, et al.
Pharmacotherapy|July 29, 2008
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR studyNathan P Clark, Daniel M Witt, Thomas Delate, et al.
Blood Advances|March 10, 2019
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysisRasha Khatib, Maja Ludwikowska, Daniel M Witt, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
Archives of Internal Medicine|September 19, 2012
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleedingDaniel M Witt, Thomas Delate, David A Garcia, et al.
The American Journal of Medicine|February 21, 2023
Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus PanelRachel P Rosovsky, Eva Kline-Rogers, Leslie Lake, et al.
Plos One|January 29, 2025
The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adultsAnna L Parks, Stacey L Slager, Amy M Cizik, et al.
Pageof 17